Search Results - "Reismüller, Bettina"
-
1
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
Published in Haematologica (Roma) (01-09-2019)“…Asparagine levels in cerebrospinal fluid and serum asparaginase activity were monitored in children with acute lymphoblastic leukemia treated with…”
Get full text
Journal Article -
2
B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH -Rearranged B-ALL
Published in Frontiers in oncology (10-12-2019)“…B-cell acute lymphoblastic leukemia associated with t(5;14)(q31;q32); is an exceptional cause of eosinophilia. The enhancer on 14q32 is juxtaposed to the gene…”
Get full text
Journal Article -
3
Was muss bei der Praxiseröffnung alles bedacht werden?
Published in Monatsschrift Kinderheilkunde (01-09-2022)“…Zusammenfassung In Österreich droht die Unterversorgung von Kindern im Gesundheitsbereich aufgrund nichtbesetzter pädiatrischer Kassenplanstellen. Allein in…”
Get full text
Journal Article -
4
Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20+ malignancies: An international retrospective study
Published in American journal of hematology (01-05-2016)“…Central nervous system (CNS) involvement in patients with mature B non‐Hodgkin lymphoma, post‐transplantation proliferative disorder and acute lymphoblastic…”
Get full text
Journal Article -
5
Feasibility and tolerability of bevacizumab in children with primary CNS tumors
Published in Pediatric blood & cancer (01-05-2010)“…Background Bevacizumab, an antibody to the vascular endothelial growth factor, has demonstrated anti‐cancer activity in a number of solid tumors. Fear of…”
Get full text
Journal Article -
6
Perception and management of cancer predisposition in pediatric cancer centers: A European‐wide questionnaire‐based survey
Published in Pediatric blood & cancer (01-05-2023)“…The European Union‐funded COST Action (LEukaemia GENe Discovery by data sharing, mining, and collaboration) LEGEND was an international and multidisciplinary…”
Get full text
Journal Article -
7
High hyperdiploid acute lymphoblastic leukemia (ALL)—A 25‐year population‐based survey of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group
Published in Pediatric blood & cancer (01-06-2017)“…Background Approximately 30% of childhood acute lymphoblastic leukemia (ALL) cases are high hyperdiploid (HD). Despite their low relative recurrence risk, this…”
Get full text
Journal Article -
8
Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group
Published in Journal of pediatric hematology/oncology (01-07-2013)“…We analyzed outcome of a population-based cohort of 74 children with second and third acute lymphoblastic leukemia (ALL) relapse and aimed to identify…”
Get full text
Journal Article -
9
The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group
Published in British journal of haematology (01-05-2013)“…Summary Adolescents aged 15–18 years with acute lymphoblastic leukaemia (ALL) have been historically reported to have a poorer prognosis than younger children…”
Get full text
Journal Article -
10
Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group
Published in British journal of haematology (01-02-2009)“…Summary Relapsed acute lymphoblastic leukaemia (ALL) is the most common cause for a fatal outcome in paediatric oncology. Although initial ALL cure rates have…”
Get full text
Journal Article -
11
The inferior prognosis of adolescents with acute lymphoblastic leukaemia ( ALL ) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the A ustrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group
Published in British journal of haematology (01-05-2013)“…Summary Adolescents aged 15–18 years with acute lymphoblastic leukaemia ( ALL ) have been historically reported to have a poorer prognosis than younger…”
Get full text
Journal Article -
12
Kopf- und Halstumore im Kindesalter: Epidemiologie, klinische Aspekte und Differentialdiagnosen
Published in Pädiatrie und Pädologie (01-12-2011)Get full text
Journal Article -
13